Table 4 COQ level in the skin fibroblasts in patients with COQ4 mutation
Patient | Tissue | COQ level | CI | CI+III | CII | CII+III | CIII | CIV |
|---|---|---|---|---|---|---|---|---|
1 | Skin fibroblast | 0.4 pmol/U COX (1.64–3.32) | Normal | Not done | Normal | 130 mU/U COX (269–781) | Normal | Normal |
6 | Skin fibroblast | 0.63 pmol/U CS (1.04–2.92) | Normal | Not done | Normal | 183 mU/U COX (269–781) | Normal | Normal |
7 | Skin fibroblast | 0.4 pmol/UCOX (1.64–3.32) | Not done | Not done | Normal | 183 mU/UCOX (269–781) | Normal | Not done |
8 | Muscle | 191 pmol/mg (140–580) | Normal | Not done | Normal | Not done | Normal | Normal |
Skin fibroblast | 0.29 nmol/UCOX (1.64–3.32) | Normal | Not done | Normal | 135 mU/U COX (control 269–781 in the skin) | Normal | Normal | |
9 | Skin fibroblast | 16.4 ng/mg prot (46.1 ± 3) | Not done | 64% of CS | 90% of CS | 55% of CS | Not done | 67% of CS |